To recognize Blood Clot Awareness Month in March, Congresswoman Lisa Blunt Rochester (D-Del.) unveiled a comprehensive toolkit titled “Blood Clot Awareness, Action, and Advocacy: The Toolkit.” This document contains information on blood clots, Blunt Rochester’s bipartisan work in Congress to spread awareness of blood clots, and ways the public can advocate for themselves and others at the doctor’s office and online. Blunt Rochester was joined for the announcement last week by Congressman Paul Tonko (D-N.Y.) as well as representatives from the Centers for Disease Control and Prevention (CDC), the National Blood Clot Alliance, ChristianaCare, and the Delaware Chapter of the American Heart Association.
“As the nation’s leading patient advocacy organization focused on the prevention, early diagnosis, and treatment of life-threatening blood clots such as deep vein thrombosis and pulmonary embolism, the National Blood Clot Alliance “NBCA” unequivocally supports the passage of the Charles Rochester Blood Clot Prevention and Treatment Act. As a pulmonary embolism survivor, and as the president of NBCA, I have witnessed first-hand the unnecessary death and devastation caused by blood clots. NBCA calls on Congress to protect the American public from this silent killer by supporting the Charles Rochester Blood Clot Prevention and Treatment Act. Together, we can #StoptheClot,” said Leslie Lake, President, National Blood Clot Alliance. NBCA is a CNTR Affiliate member.
CNTR recently provided a letter of support for Blunt Rochester’s bipartisan Blood Clot Prevention and Treatment Act (H.R. 5699), which she introduced in honor of her late husband who died from blood clots. That legislation would direct the Centers for Disease Control and Prevention to launch a national campaign to increase public awareness of blood clot signs and symptoms and would establish an advisory committee to help streamline effective diagnosis, treatment, and prevention of blood clots and pulmonary embolisms.